Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1991 1
1993 1
1994 4
1995 7
1996 3
1997 7
1998 1
1999 1
2000 3
2001 4
2003 3
2004 2
2005 5
2006 6
2007 5
2008 6
2009 4
2010 4
2011 3
2012 6
2013 7
2014 2
2015 6
2016 5
2017 2
2018 2
2019 2
2020 1
2021 3
2022 4
2023 1

Text availability

Article attribute

Article type

Publication date

Search Results

107 results

Results by year

Filters applied: . Clear all
Page 1
Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.
Wells SA Jr, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, Lee N, Machens A, Moley JF, Pacini F, Raue F, Frank-Raue K, Robinson B, Rosenthal MS, Santoro M, Schlumberger M, Shah M, Waguespack SG; American Thyroid Association Guidelines Task Force on Medullary Thyroid Carcinoma. Wells SA Jr, et al. Thyroid. 2015 Jun;25(6):567-610. doi: 10.1089/thy.2014.0335. Thyroid. 2015. PMID: 25810047 Free PMC article. Review.
INTRODUCTION: The American Thyroid Association appointed a Task Force of experts to revise the original Medullary Thyroid Carcinoma: Management Guidelines of the American Thyroid Association. ...RESULTS: The revised guidelines are focused primar …
INTRODUCTION: The American Thyroid Association appointed a Task Force of experts to revise the original Medullary Thyroid …
Molecular targets of tyrosine kinase inhibitors in thyroid cancer.
Fallahi P, Ferrari SM, Galdiero MR, Varricchi G, Elia G, Ragusa F, Paparo SR, Benvenga S, Antonelli A. Fallahi P, et al. Semin Cancer Biol. 2022 Feb;79:180-196. doi: 10.1016/j.semcancer.2020.11.013. Epub 2020 Nov 26. Semin Cancer Biol. 2022. PMID: 33249201 Review.
Thyroid cancer (TC) is the eighth most frequently diagnosed cancer worldwide with a rising incidence in the past 20 years. Surgery is the primary strategy of therapy for patients with medullary TC (MTC) and differentiated TC (DTC). In DTC patients, radioactive iodin …
Thyroid cancer (TC) is the eighth most frequently diagnosed cancer worldwide with a rising incidence in the past 20 years. Surgery is …
Sporadic Medullary Thyroid Carcinoma: Towards a Precision Medicine.
Matrone A, Gambale C, Prete A, Elisei R. Matrone A, et al. Front Endocrinol (Lausanne). 2022 Mar 29;13:864253. doi: 10.3389/fendo.2022.864253. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35422765 Free PMC article. Review.
Medullary thyroid carcinoma (MTC) is a neuroendocrine malignant tumor originating from parafollicular C-cells producing calcitonin. Most of cases (75%) are sporadic while the remaining (25%) are hereditary. In these latter cases medullary thyroid …
Medullary thyroid carcinoma (MTC) is a neuroendocrine malignant tumor originating from parafollicular C-cells producing …
Genetics of medullary thyroid cancer: An overview.
Accardo G, Conzo G, Esposito D, Gambardella C, Mazzella M, Castaldo F, Di Donna C, Polistena A, Avenia N, Colantuoni V, Giugliano D, Pasquali D. Accardo G, et al. Int J Surg. 2017 May;41 Suppl 1:S2-S6. doi: 10.1016/j.ijsu.2017.02.064. Int J Surg. 2017. PMID: 28506408 Free article. Review.
Medullary thyroid carcinoma (MTC) represents 3-5% of thyroid cancers. 75% is sporadic and 25% is the dominant component of the hereditary multiple endocrine neoplasia (MEN) type 2 syndromes. Three different subtypes of MEN2, such as MEN2A, MEN2B, and …
Medullary thyroid carcinoma (MTC) represents 3-5% of thyroid cancers. 75% is sporadic and 25% is the dominant co …
Genomics and Epigenomics of Medullary Thyroid Carcinoma: From Sporadic Disease to Familial Manifestations.
Barletta JA, Nosé V, Sadow PM. Barletta JA, et al. Endocr Pathol. 2021 Mar;32(1):35-43. doi: 10.1007/s12022-021-09664-3. Epub 2021 Jan 25. Endocr Pathol. 2021. PMID: 33492588 Free PMC article. Review.
Our understanding of the genomics and epigenomics of medullary thyroid carcinoma (MTC) has advanced since the initial recognition of RET as a driver of MTC tumorigenesis in familial MTC. ...For example, the most common RET mutation in sporadic MTC is t …
Our understanding of the genomics and epigenomics of medullary thyroid carcinoma (MTC) has advanced since the initial r …
Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update.
Wells SA Jr, Pacini F, Robinson BG, Santoro M. Wells SA Jr, et al. J Clin Endocrinol Metab. 2013 Aug;98(8):3149-64. doi: 10.1210/jc.2013-1204. Epub 2013 Jun 6. J Clin Endocrinol Metab. 2013. PMID: 23744408 Free PMC article. Review.
CONTEXT: Over the last decade, our knowledge of the multiple endocrine neoplasia (MEN) type 2 syndromes MEN2A and MEN2B and familial medullary thyroid carcinoma (FMTC) has expanded greatly. In this manuscript, we summarize how recent discoveries have e …
CONTEXT: Over the last decade, our knowledge of the multiple endocrine neoplasia (MEN) type 2 syndromes MEN2A and MEN2B and familial …
Sporadic and familial medullary thyroid carcinoma: state of the art.
Moo-Young TA, Traugott AL, Moley JF. Moo-Young TA, et al. Surg Clin North Am. 2009 Oct;89(5):1193-204. doi: 10.1016/j.suc.2009.06.021. Surg Clin North Am. 2009. PMID: 19836492 Free PMC article. Review.
Medullary thyroid cancer (MTC) accounts for 5% to 10% of all thyroid cancers. The high frequency of familial cases mandates screening and genetic testing. The aggressiveness and age of onset of familial MTC differs depending on the specific gene …
Medullary thyroid cancer (MTC) accounts for 5% to 10% of all thyroid cancers. The high frequency of familial cas …
Medullary thyroid carcinoma.
Griebeler ML, Gharib H, Thompson GB. Griebeler ML, et al. Endocr Pract. 2013 Jul-Aug;19(4):703-11. doi: 10.4158/EP12430.RA. Endocr Pract. 2013. PMID: 23512389 Review.
OBJECTIVE: This review outlines advances in the diagnosis, genetic testing, and progress in medullary thyroid cancer (MTC) treatment in light of the most recent evidence. ...RESULTS: MTC is an uncommon neuroendocrine malignancy that accounts for 5% of thyroid …
OBJECTIVE: This review outlines advances in the diagnosis, genetic testing, and progress in medullary thyroid cancer (MTC) tre …
Susceptibility Genes and Chromosomal Regions Associated With Non-Syndromic Familial Non-Medullary Thyroid Carcinoma: Some Pathogenetic and Diagnostic Keys.
Sánchez-Ares M, Cameselle-García S, Abdulkader-Nallib I, Rodríguez-Carnero G, Beiras-Sarasquete C, Puñal-Rodríguez JA, Cameselle-Teijeiro JM. Sánchez-Ares M, et al. Front Endocrinol (Lausanne). 2022 Feb 28;13:829103. doi: 10.3389/fendo.2022.829103. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35295987 Free PMC article. Review.
Thyroid cancer is the malignant tumor that is increasing most rapidly in the world, mainly at the expense of sporadic papillary thyroid carcinoma. ...Non-syndromic familial non-medullary carcinoma has a complex and heterogeneous genetic b …
Thyroid cancer is the malignant tumor that is increasing most rapidly in the world, mainly at the expense of sporadic papillary th …
[Familial medullary thyroid carcinoma: case report and literature review.].
Barletta Carrillo CF, Poterico Rojas JA, Barrionuevo Cornejo C, Casavilca Zambrano S, Pinedo Cárdenas A, Quispe Santibañez I, Castro Mujica MDC. Barletta Carrillo CF, et al. Rev Fac Cien Med Univ Nac Cordoba. 2018 Dec 12;75(4):303-309. doi: 10.31053/1853.0605.v75.n4.20947. Rev Fac Cien Med Univ Nac Cordoba. 2018. PMID: 30734711 Review. Spanish.
Medullary thyroid carcinoma (MTC) is a malignant tumour of the calcitonin-secreting parafollicular C cells of the thyroid gland. Up to 25% of MTC are associated to pathogenic germinal variants on the proto-oncogene RET (locus 10q11.2), which cause F …
Medullary thyroid carcinoma (MTC) is a malignant tumour of the calcitonin-secreting parafollicular C cells of the th …
107 results